DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
-2.73%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$4.75B
AUM Growth
+$4.75B
(+6.2%)
Cap. Flow
+$377M
Cap. Flow
% of AUM
7.95%
Top 10 Holdings %
Top 10 Hldgs %
38.71%
Holding
141
New
13
Increased
21
Reduced
12
Closed
13
Top Buys
| 1 |
IMGN
Immunogen Inc
IMGN
|
$52M |
| 2 |
Gilead Sciences
GILD
|
$48.7M |
| 3 |
Cogent Biosciences
COGT
|
$38.6M |
| 4 |
Merus
MRUS
|
$35.1M |
| 5 |
Neurocrine Biosciences
NBIX
|
$34.6M |
Top Sells
| 1 |
Kura Oncology
KURA
|
$32.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$22.2M |
| 3 |
Organogenesis Holdings
ORGO
|
$19.6M |
| 4 |
GoodRx Holdings
GDRX
|
$18.9M |
| 5 |
Nuvation Bio
NUVB
|
$18.8M |
Sector Composition
| 1 | Healthcare | 52.41% |
| 2 | Financials | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Nuvalent
NUVL
$5.52B
| $262M | 5.41% | 19,341,024 | – | – |
|
2
Viatris
VTRS
$12.3B
| $216M | 4.46% | 20,673,700 | – | – |
|
3
AdaptHealth
AHCO
$1.28B
| $201M | 4.15% | 11,150,797 -499,275 | -4% | -$9.01M |
|
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $196M | 4.05% | 2,012,714 +354,914 | +21% | +$34.6M |
|
|
SILK
5
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $97.4M | 2.01% | 2,676,891 +523,179 | +24% | +$19M |
|
|
6
Gilead Sciences
GILD
$140B
| $96M | 1.98% | 1,552,639 +787,150 | +103% | +$48.7M |
|
|
DCPH
7
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $82.2M | 1.7% | 6,250,964 +670,508 | +12% | +$8.82M |
|
|
IMGN
8
DELISTED
Immunogen Inc
IMGN
| $67.6M | 1.39% | 15,020,490 +11,549,815 | +333% | +$52M |
|
9
Mirum Pharmaceuticals
MIRM
$3.71B
| $63.1M | 1.3% | 3,244,434 -38,478 | -1% | -$749K |
|
10
Day One Biopharmaceuticals
DAWN
$769M
| $62.9M | 1.3% | 3,512,123 +1,425,674 | +68% | +$25.5M |
|
|
CMAX
11
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $57.6M | 1.19% | 15,861,090 | – | – |
|
|
12
Cogent Biosciences
COGT
$1.69B
| $53M | 1.09% | 5,876,805 +4,275,805 | +267% | +$38.6M |
|
13
Pulmonx
LUNG
$69.7M
| $51M | 1.05% | 3,465,901 -229,440 | -6% | -$3.38M |
|
|
ISEE
14
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $50.2M | 1.03% | 5,214,000 +322,004 | +7% | +$3.1M |
|
15
Centene
CNC
$14.3B
| $49M | 1.01% | 578,800 +25,000 | +5% | +$2.12M |
|
|
16
Kura Oncology
KURA
$686M
| $48.2M | 0.99% | 2,627,000 -1,789,361 | -41% | -$32.8M |
|
17
Glaukos
GKOS
$5.5B
| $47.2M | 0.97% | 1,039,514 +670,000 | +181% | +$30.4M |
|
18
Molina Healthcare
MOH
$9.8B
| $46.7M | 0.96% | 167,000 +32,011 | +24% | +$8.95M |
|
19
Cytokinetics
CYTK
$4.23B
| $45.6M | 0.94% | 1,160,315 +207,612 | +22% | +$8.16M |
|
|
20
Merus
MRUS
$4.98B
| $45M | 0.93% | 1,985,924 +1,548,924 | +354% | +$35.1M |
|
21
Evolus
EOLS
$494M
| $42.1M | 0.87% | 3,632,751 +2,403,517 | +196% | +$27.9M |
|
22
Brookdale Senior Living
BKD
$1.83B
| $39M | 0.8% | 8,592,461 +3,213,461 | +60% | +$14.6M |
|
|
AERI
23
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $35.2M | 0.73% | 4,695,020 | – | – |
|
24
Edgewise Therapeutics
EWTX
$1.51B
| $31.3M | 0.65% | 3,933,137 | – | – |
|
25
HilleVax
HLVX
$105M
| $28.6M | 0.59% | +2,617,948 | New | +$28.6M |
|